No Data
No Data
Jefferies Remains a Buy on Immutep Ltd (PRRUF)
Immutep Secures Regulatory Clearance for Phase 1 Antibody Study in Autoimmune Diseases; Shares Up 3%
Immutep (ASX:IMM) secured regulatory clearance from the ethics and competent authority in the Netherlands for its phase one study investigating the safety, pharmacokinetic, and pharmacodynamic
Rising US Rate Cut Bets Lift Australian Shares to Record High
Australian shares rose to a record high on Friday as investor bets for a rate cut by the US Federal Reserve grew stronger after softer-than-expected US inflation data.The S&P/ASX 200 Index surged 69.7
Immutep Surges 19% Following Positive Results in Head, Neck Cancer Trial
Immutep (ASX:IMM) shares jumped 19% after reporting positive results from Cohort B of the TACTI-003 Phase IIb trial.The results showed that eftilagimod alfa in combination with KEYTRUDA demonstrated
Stocks of the Hour: Immutep, Middle Island Resources, Inca Minerals
To register for today's webinar click here.Immutep (ASX:IMM) has announced positive results from Cohort B of the TACTI-003 Phase IIb trial: Eftilagimod alfa (efti) in combination with KEYTRUDA. The
Why Is This ASX Healthcare Stock Rocketing 25% on Friday?
Immutep Ltd (ASX: IMM) shares are ending the week with a bang.
No Data